In view of the stronger inhibitory effects of GYF-21 on microglia and the important roles that STAT1/3 signaling pathways play in adaptive immune cells, we will investigate the inhibitory activity of GYF-21 on innate and adaptive immunity and underlying mechanisms, as well as reveal its potential to treat multiple sclerosis. The gene discussed is STAT1; the disease is multiple sclerosis.